Pattern-Based Trials Show Stronger Chinese Herbal Results
A review of 378 placebo-controlled trials links use of traditional Chinese medicine patterns in patient selection to higher rates of statistically significant outcomes.
Updated on Nov. 5, 2026 in Alternative Medicine
An analysis of 378 published randomized placebo-controlled trials of Chinese herbal formulas found that trials using traditional Chinese medicine patterns as an inclusion criterion reported significant primary outcomes more often. Of the trials, 52.1% used pattern-based inclusion, with 94.9% of those reporting significant primary outcomes versus 75.7% of trials that did not.
Why it matters
The findings suggest that how patients are selected may influence trial results for herbal medicines, a factor that bears on how such evidence is interpreted. The analysis also notes that only 13.8% of the trials were assessed as having a low risk of bias, which limits confidence in the pattern-based association.
The analysis drew on 378 trials covering 92,691 participants, with a 14% higher likelihood of significant outcomes for pattern-based trials after adjustment (adjusted risk ratio 1.14; 95% CI 1.06-1.23). Only 52 trials (13.8%) were rated low risk of bias, and whether pattern selection itself drives the difference remains unresolved.
The details
Researchers classified trials by whether they used traditional Chinese medicine patterns as an inclusion criterion and adjusted for four prespecified trial characteristics. The trials were identified through eight databases and were published between January 1, 2020, and October 21, 2025.
Timeline
Trials analyzed were published between January 1, 2020, and October 21, 2025.
The analysis was published on November 5, 2026.
Roadmap
Chinese herbal medicine has increasingly been tested under the randomized placebo-controlled standards used for conventional drugs, and this analysis examines whether the diagnostic framework of traditional patterns affects those results. The finding points to patient selection as a variable that trial designers in this field may need to standardize.
Readers considering herbal remedies should note that reported benefits in trials may depend on how participants were selected. Decisions about these treatments are best made with a licensed clinician who can weigh the quality of the underlying evidence.
The takeaway
Trial results for herbal medicines can vary with how patients are chosen, so the quality of the underlying study design matters when weighing reported benefits. Readers should treat pattern-based findings as a signal for further rigorous testing rather than settled evidence.
Further reading
For broader context on how these therapies are studied, see Alternative Medicine.
Source note: This article includes information reported by News-Medical.
